menu close
kallyope.com

Kallyope Stock

Company Profile:

Kallyope is a biotechnology company focused on harnessing the gut-brain axis to develop innovative therapies for various health conditions. Kallyope aims to unlock the complex interactions between metabolic, neurological, and gastrointestinal systems to create effective treatments for diseases such as obesity, diabetes, and neurological disorders.

Sign up for SecondMarket™ to view the market and buy or sell Kallyope Stock
Buy + Sell

Kallyope Funding

Sign up to gain insights into Kallyope funding history, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Date Financing Round Amount Price per share* Valuation*
Feb 15, 2022 Series D 236.00M
Price
Valuation
Mar 18, 2020 Series C 112.50M
Price
Valuation
Dec 05, 2018 Series B 20.76M
Price
Valuation
Feb 22, 2018 Series B 66.15M
Price
Valuation
Oct 27, 2016 Series A 16.00M
Price
Valuation
Sep 30, 2015 Series A 12.05M
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D™

Leverage Your Equity to Help Achieve More.

Kallyope Management Team

  • Chief Marketing Officer

    Amanda Cole

  • Chief Commercial Officer

    Mark Myers

  • Director

    Peter Hecht

  • Director

    Fritz Lanman

  • Co-Founder, Solution Architect

    Diego Netto

  • Co-founder, CEO, Director

    Ross Lipson

  • Director

    Scott Tobin

  • COO

    Jason Snodgress

  • Director

    Phil Venables

  • Director

    Enrique Salem

  • Director

    Kevin Diestel

  • Director

    Hemant Taneja

  • Director

    Mamoon Hamid

  • Director

    Jerry Chen

Kallyope Major Investors

  • Alexandria Venture Investments

  • Column Group

  • Tao Capital Partners

  • Two Sigma Ventures

  • DNS Capital, LLC

  • DNS Capital, LLC

  • Hartford HealthCare Endowment

  • Mubadala Investment Company

  • Casdin Capital

  • Polaris Partners

  • Euclidean Capital

  • Greenspring Associates, Inc

  • Greenspring Associates, Inc

  • Parkwood LLC

  • StepStone Group LLC

  • Illumina, Inc.

  • Illumina, Inc.

  • Lux Capital

Learn More About Kallyope Stock

Buy Kallyope Stock
01
Kallyope stock does not trade on public stock exchanges. Kallyope stock is considered a private security and you need to be an accredited investor to purchase shares. To invest in Kallyope stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market. Get started to begin exploring private market opportunities.
Sell Kallyope Stock
02
Kallyope Stock does not trade on public stock exchanges. In order to sell Kallyope shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors. Get started to begin exploring private market opportunities.
Kallyope Stock Price
03
Kallyope does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view Kallyope share price and other valuable private market data. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Kallyope Stock Ticker Symbol
04
There is no ticker symbol for Kallyope stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company “street” name or legal name. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Criteria to Sell Kallyope Stock
05
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Kallyope stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Criteria to Buy or Invest in Kallyope Stock
06
Currently, Nasdaq Private Market only works with institutional investors to purchase private company stock. In order to invest in Kallyope stock you need to be an institutional investor. Get started to begin exploring the Nasdaq Private Market Tape D™ database.
Kallyope Stock Settlement
07
Once you buy or sell stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
Kallyope IPO
08
Kallyope is a private company and has not had an IPO. There is currently no Kallyope IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to Kallyope IPO.
Sign up for SecondMarket™ to view the market and buy or sell Kallyope Stock
Buy + Sell

Other Companies

Nomi Health

Direct healthcare system that simplifies access to high-quality, affordable care for communities.

BigID

Security software that leverages advanced machine learning and identity intelligence.

Mainspring

Develops and manufactures Linear Generators to unlock the full potential of distributed power generation.

Whoop

Wearable technology to track strain, recovery, and sleep.

Retool

A no-code development platform to build internal tools.

Clay

AI platform automating customer research and personalized outreach.

Source: Nasdaq Private Market Tape D™